RICHARDSON, Texas, Sept. 17, 2019 /PRNewswire/ -- Licensed massage therapist, Kylie Ellison, LMT is pleased to announce the launch of her new massage business in Richardson, TX. Why another massage therapist you may wonder? As per Kylie, "I help both men and women achieve better health and fitnes

--- Expands licensed cannabis footprint to four U.S. states, in addition to global reach into Canada and Europe.--- Ilera's current revenue run-rate is over US$43 million 1, up from total sales in 2018 of less than US$8 million&nbs

DUBLIN, Sept. 17, 2019 /PRNewswire/ -- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY

RARITAN, N.J., Sept. 17, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from its prostate cancer and solid tumor portfolios will be featured at the European Society for Medical Oncology (ESMO) Annual Congress 2019, taking place September 27 to October 1 in

SCOTTSDALE, Ariz., Sept. 17, 2019 /PRNewswire/ -- Axon (Nasdaq: AAXN), the global leader in connected public safety technologies, today announced Axon's new empathy development training for suicide prevention, based in virtual reality. This training has been developed specifically for law enforcement agencies and is available via Axon Academy, a network of online an

REDWOOD CITY, Calif., Sept. 17, 2019 /PRNewswire/ -- REVOLUTION Medicines, Inc., a clinical-stage oncology company focused on developing novel targeted therapies to inhibit elusive frontier targets within notorious cancer pathways, today announced dosing of the first patient in an open-label, Phase 1b/2 dos

TORONTO and HOUSTON, Sept. 17, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company, today announced that it will present an update on the lead candidate from its IL-2 superkine platform, MDNA19, at the International Can

SALT LAKE CITY, Sept. 17, 2019 /PRNewswire/ -- Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company, announced today its Australian subsidiary has been awarded a $1.37 M AUD grant from the FightMND (Fight Motor Neuron Disease) foundation of Australia. The grant will substantially fund a c

BOSTON, Sept. 17, 2019 /PRNewswire/ -- SciBite, the award-winning semantic technology company, last week hosted its annual US-based customer meeting at Novartis Institutes for BioMedical Research in Boston, MA, sparking 'clean data' discussions.

TORONTO, Sept. 17, 2019 /PRNewswire/ - ACTO and Teleflex's Vascular Division won a coveted Brandon Hall Group Bronze award for excellence in the "Best Advance in Learning Technology Implementation" category for their groundbreaking efforts to improve sales performance. The ACTO and Teleflex case study demonstrates the commercial success that life sciences companies